Group One Trading
RDHL

Group One Trading’s Redhill Biopharma RDHL Stock Holding History

Group One Trading’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed -$351 – 7822
2022
Q4 		$351 Sell
3
-9
-75% -$3.9K ﹤0.01% 6987
2022
Q3 		$6K Hold
12
– – ﹤0.01% 6766
2022
Q2 		$10K Hold
12
– – ﹤0.01% 6771
2022
Q1 		$31K Sell
12
-24
-67% -$56.9K ﹤0.01% 6460
2021
Q4 		$92K Sell
36
-38
-51% -$152K ﹤0.01% 5806
2021
Q3 		$339K Buy
74
+66
+825% +$448K ﹤0.01% 4616
2021
Q2 		$52K Sell
8
-9
-53% -$62.1K ﹤0.01% 6544
2021
Q1 		$125K Buy
17
+9
+113% +$75.5K ﹤0.01% 5451
2020
Q4 		$61K Buy
+8
New +$71.9K ﹤0.01% 4884
2020
Q3 		– Sell
-2
Closed -$16.4K – 5942
2020
Q2 		$12K Sell
2
-6
-75% -$41.3K ﹤0.01% 5052
2020
Q1 		$35K Hold
8
– – ﹤0.01% 3939
2019
Q4 		$47K Buy
+8
New +$51.1K ﹤0.01% 4032

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's RDHL Position: Q1 2026 in Review

Group One Trading sold out of Redhill Biopharma (RDHL) in Q1 2026, closing a stake of 4 shares — an estimated $4 sold.

Group One Trading first reported a position in RDHL in Q3 2018 and held it in 25 quarters. The position peaked at $403K in Q2 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.

  • Group One Trading reported no remaining Redhill Biopharma position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4 Redhill Biopharma shares in Q1 2026, an estimated $4.
  • Group One Trading first reported a position in Redhill Biopharma in Q3 2018 and held it in 25 quarters.
  • Group One Trading's Redhill Biopharma position peaked at $403K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.